Abstract
Kunal Bhattacharya, Nongmaithem Randhoni Chanu, Pukar Khanal, Dibyajyoti Das
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Generation of hydrogen peroxide in cancer cells: advancing therapeutic approaches for cancer treatment
10.3390/cancers16122171 · 2024
GDNF, NGF and BDNF as therapeutic options for neurodegeneration
10.1016/j.pharmthera.2013.01.004 · 2013
Mitochondrial dysfunction and oxidative stress in Alzheimer’s disease, and Parkinson’s disease, Huntington’s disease and amyotrophic lateral sclerosis – an updated review
10.1016/j.mito.2023.05.007 · 2023
Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis
10.1073/pnas.1405158111 · 2014
Targeting mitophagy in neurodegenerative diseases
10.1038/s41573-024-01105-0 · 2025
Glutathione in the brain
10.3390/ijms22095010 · 2021
Neurotoxicity assays
2022
Blood catalase, superoxide dismutase, and glutathione peroxidase activities in alcohol- and opioid-addicted patients
10.3390/medicina61020204 · 2025
Death receptors: signaling and modulation
10.1126/science.281.5381.1305 · 1998
Reactive oxygen species and cell signaling
10.1016/j.bbamcr.2023.119573 · 2024
The antioxidant glutathione
10.1016/bs.vh.2022.09.002 · 2023
Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal
10.1155/2014/360438 · 2014
Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death
10.1038/nature03434 · 2005
Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target
10.1016/j.bbadis.2006.03.008 · 2006
N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities
10.1002/brb3.208 · 2014
Current trends in neurodegeneration: cross talks between oxidative stress, cell death, and inflammation
10.3390/ijms22147432 · 2021
Insight into a neuron’s preferential susceptibility to oxidative stress
10.1042/bst20130245 · 2013
Identity, structure, and function of the mitochondrial permeability transition pore: controversies, consensus, recent advances, and future directions
10.1038/s41418-023-01187-0 · 2023
Mutant huntingtin and mitochondrial dysfunction
10.1016/j.tins.2008.09.004 · 2008
Oxidative stress and mitochondrial damage in the pathogenesis of ALS: new perspectives
10.1016/j.neulet.2016.04.065 · 2017
Mitochondrial generation of superoxide and hydrogen peroxide as the source of mitochondrial redox signaling
10.1016/j.freeradbiomed.2016.04.001 · 2016
Brain oxidative stress from a phospholipid perspective
2009
Regulation of the Apaf-1–caspase-9 apoptosome
10.1242/jcs.073643 · 2010
Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis
10.1186/1471-2121-14-32 · 2013
Glutathione peroxidases
10.1016/j.bbagen.2012.11.020 · 2013
Cell biology of Parkinson’s disease: mechanisms of synaptic, lysosomal, and mitochondrial dysfunction
10.1016/j.conb.2024.102841 · 2024
Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: post-hoc analysis of Study 19 (MCI186-19) [clinical trial NCT01492686]
10.1371/journal.pone.0258614 · 2022
Model studies of the iron-catalysed Haber–Weiss cycle and the ascorbate-driven Fenton reaction
10.3109/10715769009149895 · 1990
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
10.1038/s41583-019-0132-6 · 2019
Selective ferroptosis inhibitor liproxstatin-1 attenuates neurological deficits and neuroinflammation after subarachnoid hemorrhage
10.1007/s12264-020-00620-5 · 2021
PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration
10.1186/1478-811x-8-31 · 2010
Neuroprotective effects of natural compounds on neurotoxin-induced oxidative stress and cell apoptosis
10.1080/1028415x.2020.1840035 · 2022
How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?
10.1016/j.tcb.2008.01.007 · 2008
Excitotoxic cell death
10.1002/neu.480230915 · 1992
Calcium and excitotoxic neuronal injury
10.1111/j.1749-6632.1994.tb44407.x · 1994
CIDE domains form functionally important higher-order assemblies for DNA fragmentation
10.1073/pnas.1705949114 · 2017
Mitochondrial DNA damage and its consequences for mitochondrial gene expression
10.1016/j.bbagrm.2012.06.002 · 2012
Mitochondrial targeting of quinones: therapeutic implications
10.1016/j.mito.2007.02.007 · 2007
vitro approaches to developmental neurotoxicity
2011
The unsaturated brain: an evolutionary compromise?
10.1002/jcb.23152 · 2011
Dimethyl fumarate as a versatile therapeutic agent: molecular mechanisms and potential clinical applications
10.1007/s11033-026-11478-7 · doi-reference
On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death
10.1021/acscentsci.7b00028 · doi-reference
Iron and oxidizing species in oxidative stress and Alzheimer’s disease
10.1002/agm2.12074 · doi-reference
Necroptosis in neurodegenerative diseases: a potential therapeutic target
10.1038/cddis.2017.286 · doi-reference
Pyroptosis: mechanisms and diseases
10.1038/s41392-021-00507-5 · doi-reference
The BCL-2 protein family: opposing activities that mediate cell death
10.1038/nrm2308 · doi-reference
PGC-1α mediated mitochondrial biogenesis promotes recovery and survival of neuronal cells from cellular degeneration
10.1038/s41420-024-01953-0 · doi-reference
Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress
10.1073/pnas.94.2.514 · doi-reference
Ferroptosis: process and function
10.1038/cdd.2015.158 · doi-reference
Chromatin modification of Apaf-1 restricts the apoptotic pathway in mature neurons
10.1083/jcb.200708086 · doi-reference
Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation
10.1074/jbc.274.43.30651 · doi-reference
Oxidative stress and mitochondrial impairment: key drivers in neurodegenerative disorders
10.1016/j.arr.2025.102667 · doi-reference
Modulation of inflammasome biology in age-associated neurodegenerative diseases: therapeutic potential of endogenous gasotransmitters and synthetic molecules
10.1016/j.arr.2026.103257 · doi-reference
Cuproptosis: a new form of programmed cell death
10.1038/s41423-022-00866-1 · doi-reference
From pyroptosis, apoptosis and necroptosis to PANoptosis: a mechanistic compendium of programmed cell death pathways
10.1016/j.csbj.2021.07.038 · doi-reference
Superoxide dismutases: dual roles in controlling ROS damage and regulating ROS signaling
10.1083/jcb.201708007 · doi-reference
Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease
10.1016/j.bbadis.2013.10.015 · doi-reference
NAD+ in aging, metabolism, and neurodegeneration
10.1126/science.aac4854 · doi-reference
Mechanisms of mutant SOD1 induced mitochondrial toxicity in amyotrophic lateral sclerosis
10.3389/fncel.2014.00126 · doi-reference
Regulated necrosis: the expanding network of non-apoptotic cell death pathways
10.1038/nrm3737 · doi-reference
Copper induces cell death by targeting lipoylated TCA cycle proteins
10.1126/science.abf0529 · doi-reference
Nutritional modulation of the endogenous antioxidant system in the brain–gut axis following traumatic brain injury
10.3390/nu17213404 · doi-reference
Vitamins C and E: beneficial effects from a mechanistic perspective
10.1016/j.freeradbiomed.2011.05.017 · doi-reference
Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy
10.1111/j.2042-7158.2012.01526.x · doi-reference
Rotenone, paraquat, and Parkinson’s disease
10.1289/ehp.1002839 · doi-reference
First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics
10.1111/bph.12461 · doi-reference
Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis
10.1155/2019/5080843 · doi-reference
The chemistry and biology of ferroptosis
10.1016/j.chembiol.2020.03.013 · doi-reference
Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease
10.1016/j.cell.2017.09.021 · doi-reference
Oxidative stress-induced diseases via the ASK1 signaling pathway
10.1155/2012/439587 · doi-reference
Demyelination: the role of reactive oxygen and nitrogen species
10.1111/j.1750-3639.1999.tb00212.x · doi-reference
Physiological signaling functions of reactive oxygen species in stem cells: from flies to man
10.3389/fcell.2021.714370 · doi-reference
Mutant huntingtin’s interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington’s disease
10.1093/hmg/ddr475 · doi-reference
Pyroptosis: gasdermin-mediated programmed necrotic cell death
10.1016/j.tibs.2016.10.004 · doi-reference
Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson’s disease
10.1111/j.1471-4159.2006.04333.x · doi-reference
Biochemical and molecular pathways in neurodegenerative diseases: an integrated view
10.3390/cells12182318 · doi-reference
Neurotoxic effects and biomarkers of lead exposure: a review
10.1515/reveh.2009.24.1.15 · doi-reference
Oxidative stress and the central nervous system
10.1124/jpet.116.237503 · doi-reference
Ca2+ transfer from the ER to mitochondria: when, how and why
10.1016/j.bbabio.2009.03.015 · doi-reference
Structural basis for the inhibition of caspase-3 by XIAP
10.1016/s0092-8674(01)00274-4 · doi-reference